SCHEMBL1753829

SCHEMBL1753829

Cc1cc(-c2c3ccccc3c(N(c3ccccc3)c3ccccc3)c3ccccc23)cc(-c2c3ccccc3c(N(c3ccccc3)c3ccccc3)c3ccccc23)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
ALOX12 P18054 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2A6 P11509 1/20 0.32
BRD9 Q9H8M2 1/20 0.32
BRD7 Q9NPI1 1/20 0.32
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
KDM4E B2RXH2 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CYP2C19 P33261 2/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753732 0.93 ACHE (0.35) ACHETSHRCYP1A2CYP2A6BRD9
SCHEMBL13222565 0.92 CYP1A2 (0.37) ACHELMNATSHRALOX12CYP1A2
SCHEMBL13222609 0.91 ALDH1A1 (0.35) ACHECYP1A2KDM4ECYP2C19ALDH1A1
SCHEMBL13222601 0.89 ACHE (0.37) ACHELMNATSHRALOX12KDM4E
SCHEMBL14181738 0.89 CYP1A2 (0.39) CYP1A2CYP2A6KDM4EHSD17B10CYP2C19
SCHEMBL14337235 0.89 ALDH1A1 (0.34) ACHECYP1A2KDM4ECYP2C19ALDH1A1
SCHEMBL14336837 0.89 TSHR (0.37) TSHRNPSR1ALDH1A1CYP2D6MAPT
SCHEMBL14181740 0.87 ACHE (0.38) ACHEKDM4ENPSR1HSD17B10ALDH1A1
SCHEMBL13222573 0.87 ACHE (0.35) ACHECYP1A2KDM4ENPSR1HSD17B10
SCHEMBL12721978 0.86 ACHE (0.41) ACHELMNATSHRALOX12CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120168739-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2012-07-05 US disclosed
US-20120168739-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2012-07-05 US disclosed
US-8158835-B2 Fluorene compound and organic electroluminescence device CANON KABUSHIKI KAISHA (JP) 2012-04-17 US disclosed
US-8158835-B2 Fluorene compound and organic electroluminescence device CANON KABUSHIKI KAISHA (JP) 2012-04-17 US disclosed
US-7785719-B2 improved luminescence and durability; for displays of personal computers, TVs, digital cameras and video cameras CANON KABUSHIKI KAISHA (JP) 2010-08-31 US disclosed
US-7785719-B2 improved luminescence and durability; for displays of personal computers, TVs, digital cameras and video cameras CANON KABUSHIKI KAISHA (JP) 2010-08-31 US disclosed
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2009-08-13 US disclosed
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2009-08-13 US disclosed
US-7491450-B2 Organic electroluminescent device CANON KABUSHIKI KAISHA (JP) 2009-02-17 US disclosed
US-7491450-B2 Organic electroluminescent device CANON KABUSHIKI KAISHA (JP) 2009-02-17 US disclosed
US-7375250-B2 Aminoanthryl derivative substitution compound and organic electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-05-20 US disclosed
US-7375250-B2 Aminoanthryl derivative substitution compound and organic electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-05-20 US disclosed
US-7309533-B2 Substituted anthryl derivative and electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2007-12-18 US disclosed
US-7309533-B2 Substituted anthryl derivative and electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2007-12-18 US disclosed
US-7173131-B2 Anthryl derivative group substituted compound, and organic luminescent device making use of same CANON KABUSHIKI KAISHA (JP) 2007-02-06 US disclosed
US-7173131-B2 Anthryl derivative group substituted compound, and organic luminescent device making use of same CANON KABUSHIKI KAISHA (JP) 2007-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120168739-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE AFF1, LEF1, AFF2 ACHE 1093/4885LMNA 2497/4885TSHR 1706/4885
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE AFF1, LEF1, AFF2 ACHE 1093/4885LMNA 2497/4885TSHR 1706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.